Table 1.
The prevalence of disease manifestations in a cohort of midwives and nurses exposed to DM (n = 90) compared with an unexposed cohort (n = 45)
| Disease or a symptom | Study cohort (exposed) | Control cohort (nonexposed) | Exposed vs. nonexposed |
|||
|---|---|---|---|---|---|---|
| RR | 95% CI p value |
|||||
| CNS symptoms | 56/90 | 62% | 5/44 | 11% | 4.94 | 2.72–6.91 <0.001 |
| Dysfunction of peripheral nervous system | 45/90 | 50% | 4/44 | 9% | 4.36 | 1.90–7.41 0.001 |
| Asthma | 51/90 | 57% | 9/45 | 20% | 1.86 | 0.86–3.13 0.11 |
| MCS | 36/90 | 40% | 4/43 | 9% | 3.44 | 1.39–6.44 0.01 |
| Fatigue | 69/90 | 77% | 10/42 | 24% | 3.05 | 2.19–3.64 <0.001 |
| Muscle or joint pain | 46/90 | 51% | 9/41 | 22% | 2.02 | 1.11–3.02 0.02 |
| Respiratory symptoms | 72/90 | 80% | 12/42 | 29% | 2.56 | 1.84–3.04 <0.001 |
| Cardiac arrhythmia | 51/90 | 57% | 1/41 | 2.4% | 19.75 | 4.47–36.30 <0.001 |
DM, dampness microbiota; MCS, multiple chemical sensitivity; CNS, central nervous system; RR, risk ratio; CI, confidence interval.